Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Acumen Pharmaceuticals, Inc. | StockGist | StockGist

Companies
ABOS
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ABOSSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Acumen Pharmaceuticals, Inc.

Filed Aug 13, 2025

Accepted Aug 12, 2025, 8:00 PM ET

CIK 0001576885

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Acumen Pharmaceuticals, Inc.

Person Type

OO

CUSIP: 00509G209

Recent Filings

Acumen Pharmaceuticals, Inc.1 weeks ago

Acumen Pharmaceuticals, Inc.3 weeks ago

Acumen Pharmaceuticals, Inc.2 months ago

Acumen Pharmaceuticals, Inc.4 months ago

Acumen Pharmaceuticals, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice